Patents by Inventor Florian Muellershausen

Florian Muellershausen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TESIDOLUMAB FOR USE IN THE TREATMENT OF TRANSPLANT REJECTION
    Publication number: 20190225679
    Abstract: The present invention relates to the use of tesidolumab for the prevention or treatment of transplant rejection and in particular antibody mediated rejection of allografts.
    Type: Application
    Filed: June 5, 2017
    Publication date: July 25, 2019
    Inventors: Florian Muellershausen, Matthias Meier, Alan Slade, Irina Baltcheva, Mark Milton
  • ANTI-C5 ANTIBODY FOR TREATING PATIENTS WITH COMPLEMENT C5 POLYMORPHISM
    Publication number: 20190225678
    Abstract: The present invention relates generally to an anti-C5 antibody or antigen binding fragment thereof for use in the prophylaxis or treatment of a complement related disease or disorder in a patient having a polymorphism in complement C5 protein.
    Type: Application
    Filed: June 1, 2017
    Publication date: July 25, 2019
    Inventors: Florian Muellershausen, Mark Milton, Leslie Ngozi Anuna Johnson
  • AN ANTI-C5 ANTIBODY DOSING REGIMEN
    Publication number: 20190127453
    Abstract: The present invention relates to the use of an anti-C5 antibody or binding fragment thereof for the treatment of transplant rejection and in particular antibody mediated rejection of allografts.
    Type: Application
    Filed: June 5, 2017
    Publication date: May 2, 2019
    Inventors: Florian Muellershausen, Matthias Meier, Alan Slade, Irina Baltcheva, Mark Milton